Cargando…
The Efficacy and Cognitive Impact of Perampanel Monotherapy in Patients with Self-Limited Epilepsy with Centrotemporal Spikes: A Retrospective Analysis
OBJECTIVE: The third generation of antiepileptic medication (ASM) perampanel (PER), is mostly used as an add-on treatment for refractory epilepsy patients, and rarely used as a monotherapy. This study aims to observe the efficacy and assess the cognitive effects of PER monotherapy in patients with s...
Autores principales: | Yue, Xuan, Liu, Xiao-Ming, Chen, Jiao, Chen, Hai-Yun, Tan, Qian-Qian, Zhou, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237329/ https://www.ncbi.nlm.nih.gov/pubmed/37274142 http://dx.doi.org/10.2147/NDT.S410858 |
Ejemplares similares
-
Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life
por: Liu, Wan-Ting, et al.
Publicado: (2020) -
Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes
por: Suo, Gui-hai, et al.
Publicado: (2021) -
Relationship between brain activity, cognitive function, and sleep spiking activation in new-onset self-limited epilepsy with centrotemporal spikes
por: Li, Yanzhang, et al.
Publicado: (2022) -
Ictal source imaging and electroclinical correlation in self-limited epilepsy with centrotemporal spikes
por: Alving, Jørgen, et al.
Publicado: (2017) -
Changes in functional connectivity in newly diagnosed self‐limited epilepsy with centrotemporal spikes and cognitive impairment: An MEG study
por: Li, Yihan, et al.
Publicado: (2022)